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Abstract
Objective: To review the various biomarkers of dietary intakes of fatty acids in human
populations, their measurement, limitations and analytical considerations.
Design: Review of the literature.
Results: Although there is no good biomarker of intake of total fat, a number of
alternatives exist for assessing the intakes of exogenously produced fatty acids that
are consumed. Adipose tissue, erythrocyte membrane concentrations and serum or
plasma levels can reflect prior intakes over the past few hours to the past few years.
The concentrations of individual fatty acids in these media generally reflect relative
levels, and are influenced by a number of factors. Although relatively expensive to
analyse, a single analysis by gas chromatography or high-performance liquid
chromatography provides information on multiple fatty acids, and is superior to
attempting to measure specific fatty acids using traditional dietary assessment
methods.
Conclusions: Biomarkers of fatty acids that reflect long-term intake are available for
nutritional epidemiology purposes. Analytical methods have become very accurate








There are many types of biomarker and many potential
functions for biomarkers in nutritional epidemiology
studies. As presented in Table 1, they can be used as
indicators of vulnerability, markers of compliance,
markers of disease or pre-clinical disease, for validation
purposes and to estimate error matrices1. However, the
great hope is that they may also replace dietary assessment
and therefore provide unbiased, quantitative indicators of
prior dietary exposures.
Biomarkers differ from dietary intake in that they reflect
both intake and the processes involved in utilisation of the
nutrient in question. Thus, individuals with the same
dietary intake may differ in absorption, transport, uptake
in target tissues, metabolism from storage sites or
excretion. This characteristic serves to detract from their
value as a quantitative marker of food consumed, and
enhances their value as a marker of the available nutrient
or food in the study of diet and disease2. Despite the
limitation of intra-individual variability influencing bio-
marker levels, they may still be superior for hypothesis
testing than biased or non-quantitative self-reported
measures of dietary intake.
Another issue is that the time period of exposure
reflected by the biomarker differs from that of dietary
intake, in that the biomarker reflects both intake and the
processes involved in utilisation of the nutrient in
question. Biomarkers of diet can in some cases represent
an unbiased quantitative dietary intake over a specific
period of time, such as the urinary excretion of small,
water-soluble nutrients or non-nutrients in food that are
catabolised or eliminated within hours of being con-
sumed. Examples are isothiocyanates that are excreted
within hours of consumption of cruciferous vegetables;
ascorbic acid, which is excreted within a day of
consumption; and minerals such as sodium or calcium
that are eliminated largely through the urine. Alternatively,
they can be markers that accumulate in the body, whose
concentrations are associated with intakes over time and
present an integrated measure of relative consumption.
These longer-term markers are substances that are stored
in various organs, of which the sampling without
pinpointing a clearly defined exposure time window
reflects total ranking of intakes of the individual. To date,
few markers exist that can serve this function. One of the
best opportunities to use biomarkers of long-term intake is
provided by biochemical measures of some of the exo-
genously produced fatty acids. This review of fatty acid
measures as biomarkers of fatty acid intakes addresses
issues relevant to the use of biomarkers as replacements
for traditional report-based dietary assessment.
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Biomarkers of total fat intake
Measurement of the fat intakes of individuals is a long-
pursued goal that has met with little success. Fat is also one
of the most difficult dietary components to assess through
traditional methods. The reasons are many. Invisible fat is
very difficult for an individual to recognise and quantify.
Fat used in food preparation or in sauces and dressings is
often added by others than the individual under study,
making it close to impossible for the individual to identify
the source and brand of fat. Even if known, it would be
tedious to report in detail. Also, reported fat intakes are
especially prone to bias. Individuals tend to underreport
fat intake because of its social undesirability and the
problem is greater among the overweight3. Although we
still have no good biomarker of the total fat intake of
individuals, there are biomarkers sensitive to change in fat
intake and biomarkers that reflect the exposure to, or
consumption of, essential and non-essential exogenously
produced fatty acids.
Biomarkers of fatty acid intake
Unlike total fat, there are biological measurements from
readily accessible human tissues that could potentially
reflect intakes of specific fatty acids in the diet over varying
periods of time. Biomarkers of intake are valid only when
the concentrations reflect dietary intakes and are not
simply reflecting exogenous processes. Many fatty acids
can be synthesised, lengthened or desaturated endogen-
ously. These three processes are relevant to the
interpretation of fatty acid measures as biomarkers of
consumption. In the Western diet of excess, this is not
generally a severe limitation. Although saturated fats can
be synthesised endogenously, this rarely occurs in people
consuming adequate energy and more than 25% of their
energy as fat4. Therefore, body fat stores tend to reflect
long-term dietary fat consumption, except in individuals
who have been fasting or going through cycles of weight
loss and weight gain. The profile of adult body fat reflects
the profile of polyunsaturated fats after digestion and
selective metabolism have expressed their impact upon fat
tissue levels. Plasma and membrane levels also relate to
dietary intakes at various and different points in time.
Choice of a medium for biomarker-based measures
of fatty acids
The media available for assessment of dietary exposures in
man most frequently involve blood and urine, but can also
include hair, nails, skin, breath, saliva and faeces,
depending upon the storage, circulation and stability of
the nutrient. Owing to their lipid nature, fatty acids have
the strong advantage of being available in long-term
compartments such as adipose tissue, medium-term
compartments such as erythrocytes and short-term plasma
or serum components. Within serum, free fatty acids are
present in triglycerides, phospholipids and cholesterol
esters.
Chylomicrons in blood are short-lived dietary fat intake
markers that peak directly after a meal. Serum triglycerides
reflect the dietary intakes of the past hours to days, and
when the fatty acid is found in cholesterol esters and
phospholipids, it is likely to reflect consumption of a few
days earlier5.
Adipose tissue, because of its stability over time under
conditions of energy balance, is an ideal measure of long-
term dietary intakes of exogenous fatty acids. It represents
an integrated measure over time of intake6. As its measure
cannot be related directly to a quantitative intake at a
clearly defined period of time, it is therefore one of the
types of biomarker referred to as ranking or concentration
markers.
The safety of adipose tissue aspiration is comparable to
that of phlebotomy7. Adequate amounts of tissue for
specific fatty acid analyses (5–10 mg) can be collected
from various sites by aspiration using an 8-gauge needle
with or without use of local anaesthesia. The relative
distribution of individual fatty acids in adipose tissue is
Table 1 Types of biomarker in nutritional epidemiology
Biomarkers of dietary exposure:
indicate prior consumption, suitable for ranking or quantification
of prior intake
Ranking – markers that discriminate high consumers from
low consumers, such as adipose tissue levels of fat-soluble
vitamins
Quantification – markers that reflect total intake over a defined
period of time, as is the case with 24-hour urinary excretion of
calcium, sodium or B vitamin metabolites or doubly labelled
water
Biomarkers of compliance:
substances added to the diet to determine amounts consumed
Biomarkers of susceptibility:
enzymes or genetic alleles that reflect functional differences
which can affect disease risk or the ability to utilise nutrients
Biomarkers of pre-clinical disease:
biochemicals that indicate metabolic aberrations associated
with disease development
Biomarkers for validation:
measures that are used as standards against which other
reports of dietary intake are assessed
Table 2 Site-specific concentration of fatty acids*
Fatty acid (n ¼ 143) Perirenal Abdomen Buttock
C14:0 2.58 ^ 0.82 2.43 ^ 0.75 2.16 ^ 0.73
C16:0 23.76 ^ 2.40 23.13 ^ 2.11 21.79 ^ 2.51
C16:1 4.90 ^ 2.05 5.61 ^ 2.16 7.22 ^ 2.68
C18:0 6.54 ^ 1.54 5.28 ^ 1.73 4.00 ^ 1.60
C18:1 45.59 ^ 2.92 46.97 ^ 2.75 48.26 ^ 2.83
C18:2 15.36 ^ 2.93 15.32 ^ 2.85 15.37 ^ 2.82
C18:3 0.62 ^ 0.20 0.61 ^ 0.19 0.61 ^ 0.20
* Adipose tissue samples were obtained within 24 hours of death and taken
from the retroperitoneal adipose tissue anterior to the left kidney (perirenal)
and from the periumbilical region (abdominal)8.
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determined from sampling one single site in a uniform
way throughout a study. Most commonly, abdominal or
gluteal fat is used. Because of ease of access, the upper
arm is also used regularly.
Within a person, fatty acid profiles may differ across
sites. Data on the influence of site on fat profiles are
presented in Table 2, indicating similarity across sites but
also a tendency for medium-chain saturated fatty acids to
be less concentrated and monounsaturated fats to be more
highly concentrated in the buttock8. The proportion of
saturated fatty acids appears to be highest in deep-seated
sites (perirenal) vs. subcutaneous sites (abdomen and
buttocks), as evidenced from autopsies of a racially mixed
group of adults. Abdominal tissue in this study was more
heavily saturated than the gluteal fat. Although differences
were generally low, for some minor fatty acids they were
as great as 40%. Polyunsaturated fatty acid profiles,
however, were not significantly different in this sample,
suggesting that the exogenously produced fatty acids are
less site-specific.
Gas chromatography (GC) or high-performance liquid
chromatography (HPLC) is applied to quantify the peaks9.
Although the half-lives of individual fatty acids in adipose
tissue may differ, from the few studies of turnover of
linoleic acid in adipose tissue, the average half-life of fatty
acids reflects an integrated measure over one to two years
of intake6.
Under conditions of adequate or overnutrition, without
weight swings and in persons of good health, fatty acid
stores – both polyunsaturated and saturated – are likely to
reflect dietary intakes. However, pregnancy can affect fatty
acid profiles of the mother, as deposition of fat is
enhanced.
Measurement of fatty acids by GC or HPLC
Measuring the relative proportions of individual fatty acids
involves careful sample collection, sample preparation
and chromatographic analysis requiring hours per column
run, resulting in throughput of dozens of samples per day,
at best, under automated injection procedures.
Usually, fatty acids are chromatographed in the form of
methyl esters. Analyses of short-chain (C2–C6) and
medium-chain (C8–C12) fatty acids pose particular
problems. Special precautions in the analysis of such
volatile methyl esters are required to prevent excessive
losses during solvent evaporation. The less-volatile short-
chain free acids can be separated on a variety of liquid
phases, fortified with a non-volatile acid such as
phosphoric acid9, which reduces dimerisation of the free
acids.
The three methods used commonly to analyse fatty
acids are GC, liquid chromatography (LC) and gas
chromatography–mass spectrometry (GC–MS). GC is the
most popular method. Analysis of medium- and long-
chain fatty acids as their methyl esters is usually carried out
on a polar column. These columns separate fatty acid
methyl esters based on carbon number (chain length) and
position of the double bonds. Most fatty acid analysis by
GC uses a flame ionisation detector (FID). This non-
specific detector ionises carbon-containing compounds
(e.g. fatty acids) in a flame and quantifies the ions as they
elute from the column. Unfortunately, analysis occurs via a
destructive method and further analysis is impossible.
When measuring fatty acids, the sample itself is composed
of many individual fatty acids that have to be accounted
for and separated (i.e. profile). A typical profile is
composed of 20–25 peaks that correspond to individual
fatty acids ranging in length from 14 to 22 carbon atoms.
Individual fatty acids are identified by comparing their
retention times with the retention times of known
standards.
GC–MS is a powerful tool to ensure the correct iden-
tification of specific fatty acids or to elucidate the chemical
structure of fatty acid metabolites. Mass spectrometry (MS)
can detect and characterise compounds, giving definitive
structural information. The combination of GC and MS
(GC–MS) is particularly useful for lipid/fatty acid studies
because of the ease with which complex mixtures may be
separated and identified. However, the high cost and
specialised personnel required to maintain the GC–MS
preclude its use in many laboratories. Argentation thin
layer chromatography (TLC) is another technique that can
separate fatty acids based on the total number of ethylenic
bonds. However, it does not separate fatty acids with the
same number of carbon atoms.
HPLC is another method of choice for fatty acid analysis.
This analytical procedure yields the versatility of analysing
either free or derivatised (methyl esters) fatty acids. The
column eluates are monitored continuously by means of a
flow-through detector, which should be insensitive to
solvent flow rate, temperature or solvent composition. The
eluates may be collected, by means of a fraction collector,
and used for further analyses. This method of analysis uses
an ultraviolet detector, thus resulting in samples that are
not destroyed (unlike the cases of FID and MS).
Unfortunately, HPLC does not always cleanly separate
every isomer9. It is not uncommon for a laboratory to use a
combination approach: after running each sample through
HPLC, the same sample is then run through an MS detector
or submitted for GC analysis.
The separation time for each sample determines the
spectrum of fatty acids clearly separated. Scientists
typically use a 30 m column to carry out such fatty acid
separations. The length of such a column is standard,
along with an optimal separation time of about 35 minutes.
There is also a 60 m long column that allows additional
separation, but also roughly doubles the separation time
of the 30 m long column. The issue of cost efficiency also
has to be considered. However, determination of
positioning of the double bonds, cis vs. trans, requires
longer columns10.
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Silver-ion high-performance liquid chromatography
(Ag+-HPLC) is commonly used to analyse samples for
conjugated linoleic acid and other trans-fatty acids11. This
method differs from HPLC/MS in that the column is
composed of stable silver ions that are linked via ionic
bonds to phenylsulfonic acid moieties instead of a
constant bombardment of hydrogen ions. It is possible
to control many of the chromatographic parameters,
especially mobile phase composition, flow rate and
column temperature, with a high degree of accuracy. In
addition, the column can be reused, the analysis time is
short, and sample separation is simple and rapid. Samples
may be analysed by GC before and after the separation,
thus allowing determination of the quantity of trans-fatty
acids.
General issues relative to interpreting dietary intake
biomarkers
Measurement error is inherent in any biomarker. It derives
from sampling, transport and handling, and, with fatty
acids, is also related to the amount of the individual fat in
the sample available for analysis1. Assessment is related to
the size of the peak derived in the chromatogram and
proximity to other peaks in the elution sequence. Minor
fatty acids measured with GC may show coefficients of
variation greater than 25%.
An understanding of the denominator of any concen-
tration measure is essential to any biomarker-based
measure. Serum can be diluted or concentrated depending
upon physiological factors. Toenails have individual
growth rates and therefore reflect different exposure
times. Urine requires a time denominator for collection or
standardisation against a constant such as creatinine in
healthy individuals. Fatty acid levels in any biomarker
medium have the special characteristic of being a
proportion, not an absolute measure. The interpretation
of fatty acid measures requires recognition that the
measurement is the percentage that a fatty acid contributes
to the profile of all fatty acids, not the absolute amount.
Thus, greater intake of a specific fatty acid can drive down
the relative percentage of another, even though its intake
is unaltered. For this reason, quantifiable standards need
to be run during the analyses.
International variation in adipose tissue fatty acid
concentrations
Evidence of the influence of dietary differences on human
fat deposits is provided in international comparisons and
comparisons of ethnic groups residing in different parts of
the same country. Table 3 presents the mean levels of
individual fatty acids in the USA, Greece, New Zealand
and Israel for natives and emigrants from three
countries12–14. This table illustrates the fact that almost
as much difference can be found in different geographical
areas within a country as between countries. An example
of this is the profound difference in total saturated fatty
acids of the Pukapkans relative to the US-born Americans.
The proportions of monounsaturated fatty acids did not
differ as much. However, a nearly fourfold difference in
the total polyunsaturated fatty acids was noted. These
international comparisons within a genetically similar
group emphasise the importance of dietary influences
upon fatty acid profiles.
Seasonal differences in fatty acid levels in the trunk
and extremities
Few studies have systematically examined seasonal
variation in fatty acid composition of adipose tissue. One
early study, conducted in 1969 with the current technology
at that time, showed higher levels in summer of medium-
and long-chain saturated fatty acids and lower levels of
Table 4 Seasonal measures of individual fatty acids15
Leg and forearm Chest and abdomen
Fatty acid Winter Summer Winter Summer
C12:0 n/a 0.3 ^ 0.05 0.3 ^ 0.06 0.4 ^ 0.13
C14:0 2.0 ^ 0.12 3.1 ^ 0.43 3.4 ^ 0.17 3.2 ^ 0.28
C14:1 1.4 ^ 0.13 1.2 ^ 0.17 0.7 ^ 0.10 0.9 ^ 0.08
C16:0 16.5 ^ 0.40 21.0 ^ 1.21 24.1 ^ 0.77 24.4 ^ 1.57
C16:1 14.6 ^ 1.20 10.1 ^ 0.88 7.9 ^ 0.24 8.4 ^ 0.44
C18:0 1.5 ^ 0.40 2.3 ^ 0.38 4.0 ^ 0.28 4.4 ^ 0.65
C18:1 44.7 ^ 0.72 41.9 ^ 0.78 39.2 ^ 0.78 38.5 ^ 0.88
C18:2 16.4 ^ 0.68 16.5 ^ 0.60 16.8 ^ 0.76 15.9 ^ 1.69
C18:3 3.0 ^ 0.18 3.6 ^ 0.12 3.7 ^ 0.32 3.8 ^ 0.35
Total
Saturated 20.0 ^ 0.66 26.7 ^ 1.29 31.7 ^ 0.84 32.4 ^ 1.21
Monounsaturated 60.7 ^ 1.12 53.2 ^ 0.64 47.8 ^ 0.68 47.8 ^ 0.90
Polyunsaturated 19.4 ^ 0.85 20.1 ^ 0.70 20.5 ^ 0.87 19.7 ^ 1.69
n/a – not available.
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monounsaturated fats in the extremities. However, this
was not the case in the samples of the chest and abdomen.
The sum of all polyunsaturated fat levels was approxi-
mately 20% in this population and did not differ across
sites or season15 (Table 4).
Fatty acids of special interest
Five classes of fatty acids are of particular interest in
relation to dietary intakes. The polyunsaturated fats are of
special interest because they are produced exogenously
and stem from specific food sources, depending upon
the availability of specific enzymes that can help in
the formation of the polyunsaturated bonds. Among the
polyunsaturated fats, three families are distinguished: the
n 2 3, n 2 6 and n 2 9 fatty acids. Essential fatty acids of
the n 2 3 and n 2 6 families are needed for eicosanoid
production. Eicosanoids are fast acting, high-potency
hormones that are produced from free fatty acids locally.
These are oxygen-containing metabolites of fatty acid
precursors of the n 2 3 and n 2 6 families. The most
ubiquitous precursor is arachidonic acid. Dietary sources
rich in arachidonic acid include eggs, lean meats such as
poultry, organ meats and fish. Evening primrose oil is a
rich source of g-linolenic acid (C18:3n 2 6). The n 2 3
fatty acids stem largely from cold-water fish. The primary
contributor from this family to eicosanoid production is
eicosapentanoic acid. It produces odd-numbered prosta-
glandins of the 3- and 5- classes as compared with the
2- and 4- families produced from the arachidonic acid
pathway. Their products often have the inverse physio-
logical effect of the n 2 6 fatty acid eicosanoid products16.
For example, prostaglandin E2 products can be pro-
inflammatory whereas fish oil is anti-inflammatory.
A third family actively under study is the trans-fatty
acids group17. The dietary sources of trans-fats have
increased dramatically in the last decades. Although these
fatty acids can occur naturally through the rumination
process, the primary source in the American diet is from
foods in which polyunsaturated fats have been hydrogen-
ated to enhance their stability and prevent oxidation, such
as margarines, which contain 15–25% of their fat in the
trans formation17. The most common trans-fatty acid is
C18:1n 2 9 or elaidic acid. Their biological activity may
stem from their effective competition with other fatty acids
for desaturase enzymes.
Monounsaturated fats have recently received much
attention for their neutral or protective role in serum lipid
levels and for their potential involvement in breast
carcinogenesis. Canola oil is a rich dietary source of this
fat.
The fifth class of interest is the only fatty acid type
shown to be clearly and strongly preventive against cancer
(in animal models) in vivo: the conjugated linoleic acids
(CLA). These positional isomers of linoleic acid have two
double bonds at C9 and C11 (the predominant form in
foods) or C10 and C12, instead of at C9 and C12 as found in
linoleic acid. This mild difference in structure results in a
drastic difference in their impact on tumour development.
In animal experiments, linoleic acid stimulates carcino-
genesis whereas CLA feeding at 1% of the diet has been
shown to suppress mammary carcinogenesis and to
suppress linoleic acid metabolites including arachidonic
acid18,19. CLA is introduced into the diet by rumen bacteria
that contain the isomerases capable of converting linoleic
acid to CLA. Consequently, the primary dietary sources are
milk and fat-rich dairy products.
Diet–biomarker relationships
Comparisons of dietary intake reports with biomarker
measurements conducted within the same population are
often expected to yield high correlations. In fact,
correlation coefficients are often lower than 0.3, unless
adjustments for deattenuation are made. However, these
may over-inflate the true relationship. Studies that use
repeated days of dietary records or multiple 24-hour
recalls tend to have greater correlations with adipose
tissue markers than those that are food-frequency based20.
The reasons for the discrepancies are many, and are
summarised in Table 5. Measurement error is certainly
responsible for reductions in correlation. Sampling,
handling, storage, laboratory measurement; the problems
of self-reported dietary intakes; the difficulty individuals
have in identifying fat sources, particularly for foods they
did not prepare; and the error in inference of fat
Table 5 Sources of discrepancy between dietary assessment and biomarkers of fatty acid in
the same individuals (sources of variance)
Biomarkers Subjective dietary assessment
Sampling day Memory of consumption
Sampling site Portion size estimation
Laboratory measurement error Frequency estimation
Absorption Mixed dishes and their decomposition
Medium not reflective of uptake (stores) Unknown recipes
Carrier molecules Bioavailability
Genetic variance in uptake, transport, metabolism Fortification
Supplement use
Instrument-based biases
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composition of reported foods based on food composition
database values – all contribute. In addition, factors such
as selective uptake may also influence biomarker-based
measures. But beyond this, direct comparability resulting
in high correlations cannot be expected for several
reasons. First, the biomarker is subject to absorption,
metabolism and all of the factors that impact on metabolic
efficiency. Second, the site sampled will not necessarily
reflect the same time period of consumption as the dietary
intake records. Third, despite high intakes, the nutrient
may have been utilised prior to reaching storage, as is the
case with b-carotene biomarker levels in smokers.
Conclusion
Dietary assessment can be enhanced, replaced and
assessed through the use of biomarkers such as those
derived from measuring adipose tissue polyunsaturated
fatty acids. The investment in effort and cost may be
greater than for dietary assessment with traditional tools.
However, this cost is more than balanced by the value of
an objective measure of exposure. Biomarkers in general
cannot replace traditional dietary assessment methods.
There are too few biomarkers of exposure available for the
time periods of interest. However, biomarkers of dietary
exposure do belong in every nutritional epidemiology
study in one or more of the functions outlined in Table 1.
Nutritional epidemiologists need to be proactive in
insisting on the best possible dietary assessment in studies
contributing to our knowledge on the relationships
between health and diet. Getting the wrong answer is
simply too costly to choose the alternative.
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